Clinical trial
Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and…
NCT00127296 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00127296 |
|---|---|
| Title | Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe |
| Official title | Comparison of the Accuracy and Precision of NovoLog® Mix 70/30 FlexPen® to Vial and Syringe in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2, Delivery Systems |
| Intervention type | Device |
| Interventions | FlexPen®, vial and syringe |
| Enrollment | 60 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Aug 5, 2005 |
| Last update posted | Jan 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: